UNSPSC 51152016: Alcuronium

This classification denotes a nicotinic antagonist with the molecular formula C44H50N4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S8U3J5W06N. European Medicines Agency schedules Alcuronium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12766MIG. The term ALCURONIUM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 no. 12 1967, list 7.) As of Q4 2014, ALCURONIUM remains the US FDA Preferred Term for this commodity.

SMILES: OC/C=C1/C2CC3[N](CCC43C3N(C=C5C6N(C=C23)c2c(C36C6[N](CC3)(CC(=C\CO)\C5C6)CC=C)cccc2)c2c4cccc2)(C1)CC=C.

UNSPSC 51152016 Alcuronium is a Commodity code that does not reflect the work actually being solicited under it in recent state and local opportunities. The two posted opportunities tagged to this code—Seminole County, Florida's IFB for naloxone and drug deactivation systems, and the Texas Health and Human Services Commission's RFI for direct-to-manufacturer prescription programs—involve pharmaceutical procurement and pharmacy benefit management, not alcuronium, which is a neuromuscular blocking agent used in anesthesia. The code shows little relevant recent activity aligned with its nominal pharmaceutical scope.

The geographic spread of these mismatched opportunities spans Florida and Texas, but the mismatch between code taxonomy and actual procurement intent suggests that state and local procurement offices may be applying this Commodity code inconsistently or as a fallback classification. Vendors evaluating opportunities under UNSPSC 51152016 should verify the actual product or service scope in each RFP, RFQ, IFB, or ITB notice rather than relying on code name alone, as recent postings demonstrate that classification may not align with substantive buying activity.